Principles of empirical and targeted antibiotic treatment — Rapid

Synopsis

Choose, dose, review and narrow antibacterial treatment from syndrome severity, likely pathogens, resistance risk, source penetration and patient-specific toxicity rather than habit or drug familiarity.

Empirical therapy is a reasoned bridge to better information: record syndrome, likely source, severity, organisms covered, route, duration plan and review time.
Use previous microbiology, recent antibiotics, healthcare or travel exposure, colonisation, immune status and local resistance data to estimate resistant-organism risk.
Choose the narrowest regimen that safely covers the dangerous plausible pathogens and penetrates the infected compartment; more drugs do not automatically mean better treatment.
Dose for indication, weight, renal and hepatic function, age, pregnancy, allergy phenotype and altered pharmacokinetics; severe infection may require a full loading dose despite renal impairment.
At 48 to 72 hours review diagnosis, cultures, source control, response, route and duration: stop, narrow, switch, continue with an end date, or broaden only for a documented reason.
Combine antimicrobial treatment with drainage, debridement, device removal or obstruction relief whenever anatomy prevents cure by medicine alone.

Key red flags

Immediate broad coverage

Shock, meningitis, neutropenic sepsis or rapidly progressive invasive infection requires prompt syndrome-specific empirical intravenous therapy after feasible cultures.

Source-control failure

Persistent bacteraemia, collection, obstruction, necrotic tissue or prosthetic infection indicates a mechanical focus and should not trigger serial antibiotic substitutions alone.

Treatment toxicity

New kidney injury, cytopenia, liver-test abnormality, rash, diarrhoea, QT prolongation or neurotoxicity may represent antimicrobial harm requiring urgent review.

Investigation priorities

Pretreatment cultures from blood and sourceFirst step

Identify the pathogen and susceptibility while preserving the opportunity to narrow.

Management branches

Empirical startWrite a defendable initial prescription

A bacterial syndrome requires treatment before organism and susceptibility are known.

Define source, severity and dangerous pathogens; collect high-value cultures and review allergies, weight, organ function, pregnancy, interactions and previous isolates.
Select route, dose and spectrum from a current national or local syndrome guideline, give time-critical treatment promptly and document indication and review time.
Arrange source imaging or drainage, monitor response and toxicity, and communicate what result or clinical change will trigger escalation.

Key medicines

Piperacillin with tazobactamCommon severe-infection adult regimen is 4.5 g intravenously every eight hours; some protocols use every six hours.Avoid after serious immediate beta-lactam hypersensitivity and reduce maintenance in renal impairment. Review sodium and potassium, liver tests and blood counts during longer exposure; piperacillin can delay methotrexate elimination, so check the full interaction plan and de-escalate promptly.

GentamicinUse a weight-based once-daily regimen, commonly 5 to 7 mg/kg intravenously, following the local nomogram and levels.Use actual or adjusted weight and current renal function, avoid unmonitored accumulation and minimise other nephrotoxic or ototoxic drugs. Measure correctly timed concentrations and assess hearing and vestibular symptoms; pregnancy, myasthenia gravis or neuromuscular blockade requires specialist risk assessment.

Open full textbook →Answer 2 questions